Daniel O'Connor Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Daniel O'Connor.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Daniel O'Connor. Daniel O'Connor is a Director in SEELOS THERAPEUTICS, INC. ($APRI) and an Chief Executive Officer in Advaxis, Inc. ($ADXS) and a CEO in ONCOSEC MEDICAL Inc ($ONCS) and a CEO & President in ONCOSEC MEDICAL Inc ($ONCS) and a CEO and President in ONCOSEC MEDICAL Inc ($ONCS) and an Chief Executive Officer in ONCOSEC MEDICAL Inc ($ONCS) and a Director in ONCOSEC MEDICAL Inc ($ONCS).
Address: 180 VARICK STREET NEW YORK 10014 NY
Companies in which Daniel O'Connor is an Insider
Advaxis, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Daniel O'Connor: Chief Executive Officer
Holdings: 618,352 shares
Current Value: $5,657,921
Latest Transaction: Jul 03 2017
$ADXS Market Capitalization: $360.52M
$ADXS Previous Close: $9.15
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ONCOSEC MEDICAL Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Daniel O'Connor: CEO and President, CEO & President, Chief Executive Officer, CEO, Director
Holdings: 96,097 shares
Current Value: $110,512
Latest Transaction: May 04 2021
$ONCS Market Capitalization: $22.69M
$ONCS Previous Close: $1.15
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SEELOS THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Daniel O'Connor: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 07 2020
$SEEL Market Capitalization: $20.96M
$SEEL Previous Close: $2.63
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Daniel O'Connor
Sentiment: All, ADXS, ONCS, SEEL
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 04 2021 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 4.86 | 3,172 | 15,416 | 96,097 | 99.3 K to 96.1 K (-3.20 %) |
| Feb 02 2021 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 7.71 | 3,413 | 26,314 | 99,269 | 102.7 K to 99.3 K (-3.32 %) |
| Nov 03 2020 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 3.79 | 3,280 | 12,431 | 102,682 | 106 K to 102.7 K (-3.10 %) |
| Aug 26 2020 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Option Exercise | A | 3.82 | 152,000 | 580,640 | 152,000 | |
| Aug 04 2020 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 4.20 | 3,133 | 13,159 | 105,962 | 109.1 K to 106 K (-2.87 %) |
| Aug 04 2020 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 4.20 | 3,133 | 13,159 | 105,962 | 109.1 K to 106 K (-2.87 %) |
| Jun 03 2020 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Option Exercise | A | 1.56 | 304,000 | 474,240 | 304,000 |